As CD95 is now recognized as an inducer of tumor cell growth and invasion (Martin-Villalba et al., 2013; Peter et al., 2015), it is of great importance to study the CD95-induced integrin signaling in tumor progression. This evidence concerns the gene FAS and neoplasm.